Ursodeoxycholic acid vs placebo or no intervention
Non‐serious adverse events · patients with primary biliary cirrhosis.
It is very uncertain whether ursodeoxycholic acid changes non‐serious adverse events compared with placebo or no intervention (very low certainty).
1 finding from 1 review
- RR 1.46 [0.83, 2.56]12 studies · 1277 participantsVery low